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A recent surge in human mastadenovirus (HAdV) cases, including five deaths, amongst a
haematopoietic stem cell transplant population led us to use whole genome sequencing
(WGS) to investigate. We compared sequences from 37 patients collected over a 20-
month period with sequences fromGenBank and our own database of HAdVs. Maximum
likelihood trees and pairwise differences were used to evaluate genotypic relationships,
paired with the epidemiological data from routine infection prevention and control
(IPC) records and hospital activity data. During this time period, two formal outbreaks
had been declared by IPC, while WGS detected nine monophyletic clusters, seven
were corroborated by epidemiological evidence and by comparison of single-nucleotide
polymorphisms. One of the formal outbreaks was confirmed, and the other was not. Of
the five HAdV-associated deaths, three were unlinked and the remaining two considered
the source of transmission. Mixed infection was frequent (10%), providing a sentinel
source of recombination and superinfection. Immunosuppressed patients harboring a
high rate of HAdV positivity require comprehensive surveillance. As a consequence
of these findings, HAdV WGS is being incorporated routinely into clinical practice to
influence IPC policy contemporaneously.
Keywords: adenovirus, epidemiology, whole genome sequencing, pediatric infectious disease, nosocomial
transmission
INTRODUCTION
Clinical infections caused by human mastadenoviruses (HAdVs) are associated with significant
morbidity (10–89%) and mortality (6–70%) in the immunocompromised host (Echavarría, 2008).
Risk factors for poor outcome include pediatric patients (who are susceptible to primary infection),
unrelated donor stem cell transplants (SCTs), graft-vs.-host disease, T-cell depletion of graft, and
certain immunosuppressive drug regimens (Shields et al., 1985; Runde et al., 2001; Chakrabarti
et al., 2004).
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The burden of HAdV infection is significant; within the
pediatric oncology population, HAdV has been reported to
account for 15% of all diarrhoeal cases (Mhaissen et al., 2017).
Amongst pediatric patients undergoing hematopoietic stem cell
transplant (HSCT), HAdV viremia and stool shedding were
found in 15 and 42% of patients, respectively (Hiwarkar et al.,
2013; Kosulin et al., 2018). As non-enveloped viruses, HAdVs
can be resistant to standard alcohol cleaning regimens and can
survive as clinically infectious particles for up to 4 weeks (Gordon
et al., 1993). Nosocomial transmission has been frequently
reported in the literature (Russell et al., 2006; Rutala et al., 2006);
however, the identification of these outbreaks is likely to be
under-reported due to the limitations of existing HAdV typing
protocols that are performed infrequently and target only small
regions of selected genes (Seto et al., 2013).
Advances in whole genome sequencing (WGS) have provided
valuable insights into the molecular epidemiology of a number
of key hospital pathogens (Brodrick et al., 2016; Eyre et al., 2017;
Brown et al., 2019; Roy et al., 2019). This has been well-illustrated
recently in the context of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), where the application in real time
has allowed prompt feedback supporting epidemiological links
and the utility of the existing IPC policies (Meredith et al., 2020).
Specifically, within our population, a tertiary pediatric referral
center in which 30% of patients are immunocompromised,
HAdV is one of the leading causes of viral gastroenteritis,
comprising 44% of all infections (Brown et al., 2016). Over
the last financial year (2019–2020), there were 642 new HAdV
detections, from any sample site, 99 of which were viremias
(local audit data; all patient groups). Adenoviremia significantly
decreases the probability of survival in children following HSCT
and also increases the duration of inpatient hospital stay with
an associated financial burden (Faden et al., 2005; Mattner et al.,
2008; Hiwarkar et al., 2013; Swartling et al., 2015).
There is a wide range of adenovirus infections: primary new
infections with a second strain, reactivation of a previously
known infection, reactivation of a previously unknown quiescent
infection, or a mixture of these. Due to these potential
overlapping scenarios, the routine epidemiological data can
only suggest that a specific infection may be healthcare, as
opposed to community, associated but cannot confirm or refute
it. Adenovirus typing to species or serotype level may refute
a cross-infection hypothesis, but it does not provide adequate
discrimination to confirm cross infection, for which WGS is
necessary (Houldcroft et al., 2018).
Extensive efforts are employed to prevent adenovirus
infection, modified to account for local suspected transmission
routes. In our unit, we have implemented rigorous IPC policies
including environmental screening (Pankhurst et al., 2014;
Cloutman-Green et al., 2015), but transmission is still suspected.
In our hospital, over a 20-month period, seven HAdV outbreaks
have been investigated by the IPC team, two of them were
associated with the HSCT unit, and there had been five
adenovirus-associated deaths.
To further understand the routes of transmission and
enable further development of the infection control policy,
we undertook extensive epidemiological investigation and
sequencing of isolates from the HSCT unit to determine
what proportion was transmitted. Using the WGS data, we
documented the genetic relatedness between isolates and
described the possible transmission events. These findings can
be used to interrupt HAdV transmission dynamics and should




Great Ormond Street Hospital (GOSH) is a 350-bed, pediatric
tertiary referral center. Due to the immunocompromised status
of patients referred here, over 60% of beds are single room
isolation facilities. In addition to those patients who are
symptomatic, “high-risk” patients—those who are admitted for
hematological transplant or congenital immunodeficiencies—are
screened weekly and on admission for gastrointestinal infection
using polymerase chain reaction (PCR). The PCR methods
used by the GOSH diagnostic laboratory have been described
previously (Houldcroft et al., 2018). Residual diagnostic samples
were collected from patients with PCR confirmed HAdV
infection. The PCR cycle threshold (CT) values provided a
comparable semiquantitative indicator of viral titer. The use
of these samples for research was approved by The National
Research Ethics Service Committee London—Fulham (reference:
17/LO/1530). The clinical data were extracted from the hospital
databases by the GOSH Digital Research Environment (DRE)
team and linked to an anonymized patient number.
Definitions, Patients, and Samples
A HSCT unit nosocomial outbreak is suspected when any
new detection of HAdV infection is identified in a child who
was negative on admission screening. Further information
on the routine management of outbreaks is provided in
Supplementary Material. For surveillance reporting, healthcare
acquired infection (HCAI) is defined as a positive diagnostic
sample ≥48 h post-admission and community-acquired
infection (CAI) defined as a positive diagnostic sample within
48 h of admission and no healthcare contact in the preceding
14 days.
A total of 169 samples from 74 patients were included in
this study (Supplementary Table 1). All patients were known
to have either a congenital or acquired immunodeficiency, and
therefore considered high risk. As part of this investigation, 11
outbreak samples (n = 8 patients) were identified as two clusters
by IPC [infection control cluster one (ICC 1) patients: 54, 55,
56, 57, 62, and 68, and infection control cluster two (ICC 2)
patients: 40 and 38] and 37 non-outbreak samples (n = 29
patients, including HCAI and CAI infections) were sequenced
and analyzed with a local database of HAdV sequences (127
sequences from 37 patients).
SureSelect Bait Design and Sequencing
Methods allowing high-throughput HAdV WGS directly from
clinical samples have been developed (Depledge et al., 2011;
Batty et al., 2013; Houldcroft et al., 2018). These methods
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provide a proof of concept that WGS offers the resolution
required to confirm nosocomial transmission of HAdV; however,
there were technical improvements to be made with species C
viruses (85/107 clinical samples) yielding lower quality sequences
(Houldcroft et al., 2018). 120-mer baits (version 2) were
redesigned, using an in-house Perl script with a tiling factor
of 12× (each position in a given genome is covered by 12
unique bait designs) against all whole HAdV sequences (487)
in GenBank (accessed on 24 January 2018). The bait design was
uploaded to SureDesign, and biotinylated RNA oligonucleotides
(baits) were synthesized by Agilent Technologies, Santa Clara,
California (Agilent Technologies, 2021).
Quality control of sample DNA, library preparation using the
SureSelectXT Illumina paired-end protocol, and sequencing on
an IlluminaMiSeq sequencer were performed as described earlier
(Houldcroft et al., 2018), except the utilization of the SureSelectXT
low input kit. Base calling and sample demultiplexing were
performed as standard for the MiSeq platform, generating paired
FASTQ files for each sample.
Genome Mapping, Assembly, and
Phylogenetic Analysis
Sequences for all 169 samples were assembled using a reference-
based pipeline in CLC Genomics Workbench version 12.0.1
(QIAGEN, Hilden, Germany); the detailed methodology can
be found in Supplementary Figure 1. Briefly, all reads were
quality trimmed and the adaptor sequences were removed. The
trimmed reads were mapped to a reference database (n = 103),
where 90% of each read mapped with a minimum of 90%
identity, the best reference match was used to assign a genotype
to each sample. If mapped reads generated a good match to
more than one genotype, suggesting a mixed infection, samples
underwent further investigation (Supplementary Figures 1–5
and Supplementary Tables 2–6).
Once a sample had been assigned a genotype, a second
pipeline was then used to quality trim, re-map to the best
reference match with a length and similarity fraction of 0.8,
before extracting a consensus sequence. The areas of low coverage
(<10-fold) were assigned the ambiguity symbol N.
Robust consensus sequences are required for the downstream
analysis; therefore, only samples achieving ≥90% genome
coverage and ≥100-fold average read depth (quality cut-
off) were included in further analysis. Consensus sequences
(GenBank accessions MW686757–MW686857) were aligned,
and phylogenies were constructed using CLC Genomics
Workbench (version 12.0.1) (Supplementary Material).
Pairwise single-nucleotide variant counts were computed using
Molecular Evolutions Genetics Analysis (MEGA) software
version 6 (Kumar et al., 2016).
Epidemiological Support of Phylogenetic
Clusters
Where there were sufficient HAdV sequences to clearly
distinguish local UK variants from non-UK reference sequences
(species A, C, and F), monophyletic clusters, defined as groups
comprising two or more samples from at least two patients
FIGURE 1 | Incidence of new HAdV cases diagnosed using PCR by the
diagnostic laboratory. (A) The total number of HAdV cases identified by GOSH
increased each year but did not demonstrate any seasonality. (B) The
proportion of new positives that were documented as HCAI are shown in red
and (C) the proportion of new positives identified from patients admitted to the
high-risk HSCT unit are highlighted in black. Each column represents a
calendar month. HAdV, human mastadenovirus; PCR, polymerase chain
reaction; GOSH, Great Ormond Street Hospital; HCAI, healthcare-acquired
infection.
arising from a common ancestral node, with bootstrap support
≥90% were used to identify the putative outbreaks. Where there
were insufficient sequences to provide adequate phylogenetic
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FIGURE 2 | Maximum likelihood phylogenies of adenovirus full genome sequences, organized by species: (A) species A viruses, (B) species B viruses, (C) species C
viruses, (D) species E, and (E) species F viruses. Sequences were aligned and maximum likelihood phylogenies generated using CLC Genomics Workbench (version
12.0.1), 500 bootstraps. Clinical samples are labeled according to their anonymized patient number (PtX) and specimen number (_SX). Additional samples from
sequentially sampled patients have been collapsed. Inter-species reference sequences (A12, A18, and A61) were also removed from phylogeny A and from phylogeny
E (F40) to aid visualization of patient samples. The shape of each node correlates with the sample type and color, the ward on which the sample was taken. Reference
sequences are identified by their HAdV genotype and GenBank Accession. A bootstrap threshold of 80% is shown. Any clinical samples from at least two patients,
with a bootstrap support >90, were considered a cluster. The parsimony informative site for each phylogeny is as follows: (A) 2979/34444, (B) 7054/36263, (C)
3104/36332, (D) 1348/36046, and (E) 4455/34469. For phylogeny D, there are only three sequences, out of which two are identical. In this case, the sites reported
are only the variable sites between the two groups. NPA, nasopharyngeal aspirate; BAL, bronchoalveolar lavage; ET aspirate, endotracheal aspirate.
resolution (species B HAdVs), two or more samples within a
monophyletic cluster with short branch lengths (<0.002) were
used. Timelines for each monophyletic cluster were visualized
using the ggplot2 library (Wickham, 2016), incorporating patient
admission data and HAdV PCR positivity. Patients within a
cluster were defined as epidemiologically supported if they were
present on the same ward or unit becoming positive during
the incubation period of the virus [median 5.6 days (95% CI
4.8–6.3) based on respiratory disease (Lessler et al., 2009)]
and unsupported if they became positive during admissions
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to completely different wards or had no links with any other
sequenced patient.
Statistical Analysis
Statistical tests were performed using two-tailed tests at the
5% significance level within GraphPad Prism version 8.3.0 for
Mac OS, GraphPad Software, San Diego, CA, United States,
www.graphpad.com (Supplementary Material).
RESULTS
Burden of Infection and Viral Genotypes
Routine reporting of the first HAdV PCR-positive cases by the
diagnostic laboratory between 2015 and 2019 is summarized in
Figure 1. As expected, no seasonality was observed (Brown et al.,
2016); however, cases increased each year with a marked rise
between 2017 and 2018 (Figure 1A). The proportion of new cases
that were attributed to HCAI during this time period rose from
12% (2015–2017) to 23% (2018–2019) (Figure 1B). On average,
18% of new positives are detected from patients admitted to the
high-risk HSCT unit (Figure 1C).
Between August 2017 and April 2019, IPC identified 11
outbreak samples (from ICC 1 and ICC 2) and 37 non-outbreak
samples (includingHCAI and CAI cases) from high-risk patients.
Sequences were analyzed with 121 previously sequenced samples.
A total of 169 clinical samples containing HAdV genotypes A31
(14%), B3 (2%), B11 (1%), C1 (17%), C2 (21%), C5 (18%),
C89 (8%), E4 (1%), and F41 (3%) from 74 patients with either
localized (e.g., eye, respiratory, and digestive) or disseminated
infection were included. Seven of these samples (4%) failed to
sequence and 17 (10% of patients) had mixed HAdV infections
(Supplementary Table 1 and Supplementary Figure 6).
Improved Sequencing Quality
Of 169 samples across all genotypes, 56 (42%) of 132 HAdV
genomes passed the quality cut-off using version 1 baits
and 46 (85%) of 54 HAdV genomes passed using version 2
baits (Supplementary Table 1 and Supplementary Figure 7).
Both genome coverage and on-target reads were statistically
significantly improved for species C viruses using version
2 baits (Supplementary Figure 8). This was despite similar
species C viral titers in samples between bait groups
(Supplementary Figure 9). Average read depth improved
but remained significantly lower for species C viruses regardless
of the baits used (P = 0.0002 version 1 baits vs. P = 0.05 version
2 baits).
Out of the seven samples that failed to sequence, four were
sequenced using version 1 baits. Three samples failed using
version 2 baits, one with a viral load that had previously been
successful. There was an insufficient sample for repeat testing.
Using an estimated linear regression model, it is predicted that
samples with HAdV CT values of ≤34 would generate a ≤100-
fold read depth, with 95% certainty (Supplementary Figure 10).
Phylogenetic Investigation of Outbreaks
and Deaths
To substantiate nosocomial transmission, maximum likelihood
phylogenies were constructed (Figure 2). Nine monophyletic
clusters were identified (Figures 2A–E) and summarized in
Table 1. One of these clusters (A31 Cluster 4) had been previously
identified phylogenetically (Houldcroft et al., 2018).
Four of the six patients from ICC 1 (patients 55, 57, 62,
and 68) were phylogenetically linked (Figure 2A, A31 Cluster 1).
Additionally, two patients (Pt69 and Pt70) documented as having
HCAI, for whom no source of infection had previously been
identified were linked phylogenetically to ICC 1. One patient
(Pt69) involved in monophyletic A31 Cluster 1 had a mixed
HAdV infection. The sequence data obtained from Pt38 were of
insufficient quality to confirm or refute transmission with Pt40
of ICC 2 phylogenetically; however, one of these patients, Pt40,
was phylogenetically linked to another patient, Pt42, who had
a concurrent HAdV-C2 infection. WGS identified an additional
six monophyletic clusters, involving 16 patients who had not
previously been identified by standard IPC follow-up (Figure 2
and Table 1).
Out of five patients who died (patients 52, 53, 59, 60,
and 61) as a result of or in association with overwhelming
HAdV infection (Supplementary Table 1), two were linked to
a monophyletic cluster. Patient 52 was found to have a mixed
genotype (C2 and A31) infection that was dominated by a
phylogenetically unlinked C2 (Figure 2C) but with a minority
subpopulation of A31 that clustered with two other patients (11
and 73, A31 Cluster 2, Figure 2A). Patient 60 had a single C5
infection that clustered with Pt54 (C5 Cluster 3, Figure 2C). The
remaining three patients had phylogenetically unlinked single
genotype infections.
Traditional Epidemiology, Contact Tracing
Supported Phylogeny Assignments
Previous work has shown that infections can be linked over many
years (Houldcroft et al., 2018), e.g., A31 Cluster 4 potentially
transmitted over a 5-year period (temporal relationship shown
in Figure 3D). Using the new samples sequenced as part of
this investigation, we confirmed the same with a putative
transmission cluster occurring over a 3-year period (A31 Cluster
2, Figure 3B) and suggested a prolonged transmission also
occurring amongst other HAdV species, e.g., B3 Cluster 1 over
a 4-year period (Figure 3E).
Wards B and E were associated with all nine monophyletic
clusters (Figures 2, 3). As well as sharing clinical teams,
these wards are joined by the same corridor and share
facilities (dirty utility, kitchen, parents’ room and
laundry); for this reason, they are considered one HSCT
unit. Five clusters containing ward B and E patients
had temporal links with each other: A31 Cluster 1,
A31 Cluster 3, C1 Cluster 2, C5 Cluster 3, and F41
Cluster 1 (Figures 3A,C,G–I and Table 1), supporting
nosocomial transmission.
Two clusters contained one patient with no
temporal links: Pt11 in A31 Cluster 2 and Pt8 within
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A31 Cluster 1 Pt69_S1_A31 – HCAI not linked to
outbreak
B Yes 0 Confirmed transmission cluster
Pt70_S1 – HCAI not linked to
outbreak
E Yes
Pt68_S1 1 Chronic HAdV–ICC 1
investigated
E Yes
Pt62_S1 1 HCAI–ICC 1
investigated
B Yes
Pt57_S1 1 HCAI–ICC 1
investigated
B Yes
Pt55_S1 1 HCAI–ICC 1
investigated
E Yes
A31 Cluster 2 Pt11_S1 – Not classified B No 6 Likely transmission, unconfirmed
Pt73_S1_A31 – HCAI E Yes 3 Confirmed transmission cluster
Pt52_S1_A31* – HCAI E Yes
A31 Cluster 3 Pt41_S1 – CAI E Yes 1 Confirmed transmission cluster
Pt46_S1 – CAI B Yes
A31 Cluster 4 Pt24_S1 – Not classified E Yes 0–1 Confirmed transmission cluster
Pt8_S1 – Not classified B No
Pt18_S1 – Probable HCAI B Yes
Pt3_S1 – Not classified B Yes
B3 Cluster 1 Pt27_S1 – Not classified A No 13 Unlikely transmission cluster




C2 Cluster 1 Pt52_S1_C2* – HCAI E No 6 Likely transmission, unconfirmed
Pt66_S1_C2 – HCAI E No
C1 Cluster 2 Pt42_S1 – CAI E Yes 0 Confirmed transmission cluster
Pt40_S1_S2 2 HCAI–ICC 2
investigated
E Yes
C5 Cluster 3 Pt60_S1* – Not classified E Yes 0 Confirmed transmission cluster
Pt54_S1 1 HCAI–ICC 1
investigated
E Yes
F41 Cluster 1 Pt71_S1 – HCAI E Yes 0 Confirmed transmission cluster
Pt63_S1 – HCAI B Yes
Pt65_S1 – CAI B Yes 3 Confirmed transmission cluster
HAdV, human mastadenovirus; ICC, Infection Control Cluster; IPC, Infection Prevention and Control; HCAI, healthcare-acquired infection; CAI, community acquired infection.
aTemporally related, HAdV PCR positive whilst admitted to same/linked ward.
bDiversity within cluster, expressed as the number of pairwise differences/single-nucleotide polymorphisms (SNPs) across the whole genome.
*Indicates patients who died from or in association with overwhelming HAdV infection.
A31 Cluster 4 (Figures 3B,D). The two remaining
clusters (C2 Cluster 1, Figure 3F; B3 Cluster 1,
Figure 3E) did not share any temporal links with
each other.
Confidence in Genomic Links Using
Pairwise Distances
To quantify phylogenetic relationships, pairwise differences
(single-nucleotide polymorphisms [SNPs] between aligned
consensus sequences) were calculated and grouped according to
their epidemiological support (Figure 4).
Epidemiologically linked monophyletic clusters were
found to have ≤3 SNPs difference. This corroborated the
number of differences previously defined for within host
(≤2 SNPs, Figure 4C) and directly transmitted viruses
(Houldcroft et al., 2018), and further supports the nosocomial
transmission between clusters A31 Cluster 1, A31 Cluster
3, C1 Cluster 2, C5 Cluster 3, and F41 Cluster 1 (Table 1).
Of the two patients (Pt54 and Pt60) involved in C5 Cluster
3, Pt60 died; however, this patient was admitted and HAdV
PCR positive several months before Pt54 (Figure 3H),
suggesting that Pt60 may have been the source of this
nosocomial infection.
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FIGURE 3 | Temporal relationship between HAdV patients forming monophyletic clusters. Clinical data were extracted from hospital databases by the GOSH Digital
Research Environment (DRE) team and linked to an anonymized patient number. The ggplot2 library was used to visualize the data between positive adenovirus PCR
results. Sequenced samples are indicated by a vertical black line, HAdV PCR-positive samples by a red cross, HAdV PCR-negative samples by a black cross and
ward stays by colored rectangles. (A) A31 Cluster 1, (B) A31 Cluster 2, (C) A31 Cluster 3, (D) A31 Cluster 4, (E) B3 Cluster 1, (F) C2 Cluster 1, (G) C1 Cluster 2,
(H) C5 Cluster 3, and (I) F41 Cluster 1.
One monophyletic cluster, A31 Cluster 4, despite containing
one patient who was not linked temporally to the other patients
(Figure 3D), differed by 0–1 SNPs suggesting nosocomial
transmission (Table 1). With potentially unsampled patients or
environmental intermediates, it is not possible to determine the
route of transmission from these patients to the other patients
within these clusters.
The remaining monophyletic clusters A31 Cluster 2, B3
Cluster 1, and C2 Cluster 1 included at least one sequence
separated by 6–13 SNPs. This range does not overlap with the
number of SNPs found between unrelated patients of the same
genotype (14–415 SNPs). However, the interpretation of the
epidemiological links between cases based on the genomic data
alone can be difficult because we do not currently understand the
species-specific substitution rate of HAdV in chronically infected
immunosuppressed patients.
B3 Cluster 1 is the monophyletic cluster with the least
support, without a temporal relationship between patients
(admitted and tested 4 years apart) and 13 SNPs between the
two sequences (14 SNPs were found between unrelated patient
samples of the same genotype within species C viruses). Only
three B3 infections were identified during the study period
(92 and 93 SNPs separated this cluster from unrelated Pt14).
The close clustering of these samples is therefore likely to be
a result of the few publicly available UK HAdV B3 sequences.
Further sequencing of HAdV-B3 genotypes is therefore
required to substantiate the relationship found between these
two patients.
DISCUSSION
This study demonstrates the major threat to immunosuppressed
children that HAdV presents, providing a snapshot of a larger
problem as only a minority of viruses were sequenced. With
the level of infection present, it is not possible to recognize
HAdV outbreaks contemporaneously using the conventional
PCR methods. New infections identified by the diagnostic
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FIGURE 4 | Pairwise differences equating to single-nucleotide polymorphisms (SNPs) between clinical samples included in this study. (A) Pairwise differences were
plotted by the following categories: “intra patient,” differences between samples taken from the same patient; “intra cluster (epidemiologically supported),” differences
between samples from different patients within a monophyletic cluster that are temporally linked (HAdV PCR positive whilst admitted to same/linked ward) by the
admission data; “intra cluster (not epidemiologically supported),” differences between samples from different patients within a monophyletic cluster that are not linked
temporally by the admission data; “inter patient (same genotype),” differences between samples from different patients within the same genotype; “inter species,”
differences between samples from different patients within the same species but different genotypes and “intra species,” differences between samples from different
patients between species. Median values with 95% CIs are superimposed and plotted in red. (B) Differences between the first four categories to aid visualization. (C)
Highlighted precise count of pairwise differences found within the first four categories.
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laboratory by PCR (Figure 1) are also likely to be over- or under-
represented; without genomic information, it is impossible to
know whether these are genuine new infections or reactivation
of clinically quiescent virus (Kosulin et al., 2016; Dhingra
et al., 2019). WGS identified six patient clusters and 15 patient
transmission events (patients not within an ICC) which were
not identified using standard IPC investigations and whilst
only focusing on high-risk patients from two wards. Rapid
sequencing is now possible within 72 h. This has already been
shown to impact the IPC management of SARS-CoV-2 in real
time (Meredith et al., 2020) and would have impacted on the
additional six patient clusters identified here.
The utility of the WGS data is entirely dependent on the
quality of sequences obtained. Poor genome coverage and low
read depth generate tenuous links to other patients and any
SNPs identified are poorly supported. Newly designed baits
improved sequencing success (85% using version 2 baits vs.
42% using version 1 baits), especially for species C viruses
(Supplementary Figure 8). Species C HAdVs produce the
most severe clinical manifestations amongst immunosuppressed
patients, particularly those undergoing HSCT (Lion et al., 2010;
Qurashi et al., 2011).
The high incidence of mixed infection (10% of patients)
identified in this study highlights the superiority of WGS over
PCR. Not only were patients incorrectly linked using standard
methods, demonstrated by ICC 1, but HAdV PCR-positive
patients would also go unnoticed if they later acquired a second
HAdV co-infection. These secondary HAdV co-infections are
important not only because of their role in transmission events,
but also they could have different tissue tropisms, clinical
consequences and provide a sentinel source of recombination
(Lukashev et al., 2008; Walsh et al., 2009; Hashimoto et al., 2018).
This tertiary referral center already has robust IPC precautions
in place for high-risk patients; single room isolation with
en-suite facilities and environmental screening post-discharge
(Cloutman-Green et al., 2015). Despite these precautions, we
were still able to confirm that 21 patients (28%) were involved
in a nosocomial transmission cluster, and 15 patients (20%)
ordinarily would have gone unnoticed or unlinked (Table 1).
Unidentified acquisition/transmission events can have clinically
significant consequences including prolonged hospital stay,
missed treatment opportunities and even death. Sequence data
allowed us to investigate five HAdV-associated deaths as part
of the Trust Patient Safety Review process. This is important
for all the cases of HCAI where the patient may have come
to harm. In this cohort, no death was related to a virus
shown to be acquired at GOSH. The two HAdV-associated
deaths that were involved in transmission events here (Pt52 and
Pt60) appeared to be the index case in their respective clusters
(Figures 2A,C, 3B,H).
Immediate action needs to be taken to identify the source
of HAdV acquisition in these patients in order to understand
and halt transmission. Index cases may acquire their HAdV
infection outside of hospital, but we have evidence that widely
separated samples are linked; Pt8 within A31 Cluster 4, one SNP
difference (Figure 3D). This patient was immunocompromised
long term (X-linked lymphoproliferative disease) which is
known to facilitate prolonged viral shedding (Kosulin et al.,
2016). Patient 8 was, however, discharged at least 6 months
prior to related patients, and sample positivity by PCR was
absent for over 3 years. This suggests ongoing, undetected
nosocomial transmission by unsampled intermediates which
could include the environment, other patients, visiting relatives
or staff members. Outbreaks amongst vulnerable patients already
harboring a high rate of HAdV positivity requires comprehensive
surveillance. As a result, we have begun to implement routine
HAdVWGS into a standard diagnostic algorithm to improve the
clinical care.
Conclusion
The clinical utility of WGS technology for IPC purposes has
begun to be realized for a number of important pathogens
(Brodrick et al., 2016; Eyre et al., 2017; Brown et al., 2019;
Roy et al., 2019; Meredith et al., 2020). In this study, we have
demonstrated that using a sensitive technique, HCAI and mixed
infection remains a significant problem despite the application of
thorough IPC containment strategies. PCR alone fails to identify
HAdV co-infection and transmission events, which can have
catastrophic consequences amongst high-risk patients. In order
to combat this deficit, HAdV WGS is being implemented into
routine diagnostics within this tertiary referral center.
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